Back

Low basal expression and slow induction of IFITM3 puts immune cells at risk of influenza A infection

Wellington, D.; Yin, Z.; Zhang, L.; Forbester, J. L.; Kite, K.; Laurenson-Schafer, H.; Makvandi-Nejad, S.; Jin, B.; Bowes, E.; Manoharan, K.; Maldonado-Perez, D.; Verrill, C.; Humphreys, I.; Dong, T.

2019-12-23 immunology
10.1101/2019.12.20.885590 bioRxiv
Show abstract

The interferon-induced transmembrane protein, IFITM3, has been shown to restrict influenza virus infection in murine and in vitro settings for ten years, but no explanation has been found to explain why this virus infection is so highly contagious and infects most individuals it comes in contact with. We confirm that the expression level of IFITM3 plays a role in determining the level of viral infection through manipulation of IFITM3 levels with interferon (IFN) stimulation and overexpression systems. Low basal expression may put some immune cells, including lymphocytes and lung-resident macrophages, at risk of influenza virus infection. Investigating the induction of IFITM3 by IFN, we find a strong preference for Type I IFN in IFITM3 induction in both cell lines and primary human cells. While myeloid cells can increase expression following stimulation by Type I IFN, lymphocytes show minimal induction of IFITM3 following IFN stimulation, suggesting that they are always at risk of viral infection. Surprisingly, we found that the time it takes for maximal induction of IFITM3 is relatively slow for an interferon-stimulated gene at around 36 hours. Low basal expression and slow induction of IFITM3 could increase the risk of influenza virus infection in selected immune cells. ImportanceInfluenza virus infection remains one of the top ten threats to global health, causing significant deaths and hospitalisations across the world each year. Understanding mechanisms for controlling influenza virus infection remain a priority. The interferon-induced transmembrane protein IFITM3 can restrict influenza infection by limiting replication of the virus. The precise mechanisms of how IFITM3 reduced replication of influenza are unknown, although it is predicted to prevent release of viral contents into the cytosol by preventing pore formation on the endosomal compartments where it is suggested to reside. Here we have shown that the expression level of IFITM3 is important in determining the control of influenza virus infection. We find an expression pattern for IFITM3 that varies based on cell type, tissue locality, differentiation state and cell naivety, all of which highlights cells that may be at the highest risk of influenza infection.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
638 papers in training set
Top 0.5%
18.5%
2
The Journal of Immunology
166 papers in training set
Top 0.1%
15.1%
3
European Journal of Immunology
60 papers in training set
Top 0.1%
7.3%
4
ImmunoHorizons
24 papers in training set
Top 0.1%
7.3%
5
PLOS ONE
5266 papers in training set
Top 28%
5.5%
50% of probability mass above
6
Immunology
28 papers in training set
Top 0.1%
4.5%
7
Discovery Immunology
11 papers in training set
Top 0.1%
3.2%
8
iScience
1154 papers in training set
Top 8%
2.8%
9
Journal of Leukocyte Biology
42 papers in training set
Top 0.2%
2.8%
10
Scientific Reports
3612 papers in training set
Top 40%
2.6%
11
eLife
5828 papers in training set
Top 41%
2.4%
12
mBio
833 papers in training set
Top 7%
2.1%
13
Journal of Virology
499 papers in training set
Top 2%
1.7%
14
Clinical and Experimental Immunology
12 papers in training set
Top 0.1%
1.4%
15
PLOS Pathogens
820 papers in training set
Top 7%
1.3%
16
Clinical & Translational Immunology
22 papers in training set
Top 0.2%
1.1%
17
mSphere
302 papers in training set
Top 5%
1.1%
18
Cytotherapy
15 papers in training set
Top 0.2%
1.1%
19
The Journal of Infectious Diseases
202 papers in training set
Top 4%
0.9%
20
Open Biology
106 papers in training set
Top 2%
0.8%
21
Immunity, Inflammation and Disease
10 papers in training set
Top 0.5%
0.6%
22
JCI Insight
277 papers in training set
Top 9%
0.6%
23
Allergy
25 papers in training set
Top 0.5%
0.6%